Room Temperature Logistics Claims: Verification for Indian Conditions
Evaluating manufacturer claims about room-temperature transport stability for molecular diagnostic reagents in Indian logistics conditions.
Evidence Updates
Latest evidence updates on Chinese biomedical technology for India.
Random Access Under Variable Sample Volumes: An Indian Laboratory Perspective
Evaluating the practical value of Random Access capability for Indian laboratories with low and unpredictable sample volumes.
Checklist for Evaluating a Cartridge-Based Molecular Diagnostic Platform in India
A practical guide and checklist for Indian laboratory directors evaluating the iFIND cartridge-based molecular diagnostics platform, covering CDSCO status, technical specs, validation, service, and cost.
Molecular Workflow for TB and Rifampicin-Resistance Detection
Explanation of the molecular workflow behind TB and rifampicin-resistance detection in the iFIND TBR kit, including the IS6110, IS1081/IS1087, and rpoB targets. Manufacturer-provided parameters only.
iFIND TBR and IFQ: Evidence and Regulatory Questions for India
What evidence exists for the iFIND TBR and IFQ kits (manufacturer brochures only), what regulatory questions Indian labs should ask, and the unresolved IS1081/IS1087 and turnaround-time conflicts. CDSCO status not verified.
Subscribe to evidence updates
Receive notifications when new evidence or verification status changes are published. Double opt-in.